Bausch Health Companies Inc.
BHC.TO
TSX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 91.21% | 92.23% | 81.52% | -153.23% | -27.45% |
Total Depreciation and Amortization | -1.03% | 0.24% | -0.46% | -4.59% | -7.05% |
Total Amortization of Deferred Charges | -17.65% | -15.38% | 81.25% | 89.66% | -29.17% |
Total Other Non-Cash Items | -54.11% | -64.20% | -82.16% | 163.04% | 167.40% |
Change in Net Operating Assets | 95.86% | 101.20% | 89.17% | 42.16% | -17.55% |
Cash from Operations | 46.65% | 54.75% | 24.08% | 395.09% | 313.11% |
Capital Expenditure | -48.00% | -56.74% | -79.78% | -53.85% | -14.16% |
Sale of Property, Plant, and Equipment | 0.00% | 40.00% | -30.00% | 0.00% | 20.00% |
Cash Acquisitions | 92.04% | 92.80% | 97.52% | -2,346.05% | -2,346.05% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 102.70% | 126.67% | -14.29% | -12.50% | -5.71% |
Cash from Investing | 76.12% | 78.83% | 81.15% | -637.04% | -558.46% |
Total Debt Issued | -80.19% | -79.91% | -91.40% | 208.03% | -46.53% |
Total Debt Repaid | 32.02% | 14.62% | 41.19% | -31.11% | 76.16% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -7.69% | -8.33% | 0.00% | -58.82% | -44.44% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 49.43% | 47.56% | 17.39% | -14.67% | -115.29% |
Cash from Financing | -152.78% | -158.85% | -180.75% | 269.51% | 217.80% |
Foreign Exchange rate Adjustments | -400.00% | -500.00% | -14.29% | -250.00% | 77.78% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 79.46% | -35.58% | -110.60% | 102.71% | 111.61% |